Meeting Report
Lung Cancer Biomarker Speak: Teach Me the Language
Beth Sandy,(1) MSN, CRNP, and Jennifer Morrissette,(2) PhD, FACMG
From (1)Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; (2)Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2022;13(3):302–305 |
https://doi.org/10.6004/jadpro.2022.13.3.24 |
© 2022 Harborside™
ABSTRACT
A vital role of the advanced practitioner is to analyze biomarker testing reports and explain to patients how the results may impact their treatment. At JADPRO Live Virtual 2021, presenters reviewed the importance of molecular testing in non–small cell lung cancer and how to interpret molecular pathology reports.
For access to the full length article, please
sign in.
